FPA welcomes the results of a 44-year study on the long-term effects of the combined hormonal contraceptive pill. The study found that people who use the pill have no overall increased risk of cancer over their lifetime,... Read more
Leading sexual and reproductive health experts have responded to news that the Natural Cycles fertility awareness app has been approved as a class IIb medical device.
The Faculty of Sexual and Reproductive Health of the Royal College of Obstetricians and Gynaecologists (FSRH), sexual... Read more
A survey of more than 1,000 GPs across England has highlighted worrying gaps in contraceptive provision.
Just 2% of the 1,023 GPs from 914 practices questioned by FPA said they offer the full range of methods to patients, and more than half said there is not time in a standard... Read more
Did you know that there are 15 methods of contraception available in the UK?
To mark World Contraception Day 2016, we are busting some common myths and misconceptions.
... Read more
FPA is delighted to announce it has been awarded a three-year Public Health England (PHE) contract to lead a new sexual and reproductive health programme.
The Sexual Health and Reproductive Health National Information Programme will be managed by FPA on behalf of PHE to improve the... Read more
There has been lots in the news over recent days about changes to the product licence of the emergency contraceptive pill, ellaOne.
ellaOne is a tablet which contains ulipristal acetate, and it is one of three methods of emergency contraception available in the UK. It can be used up to... Read more
There are stories in the press today looking at the link between combined hormonal contraceptive (CHC) pills and blood clots, otherwise known as venous thromboembolism (VTE).
Sexual health charity FPA has urged women not to panic about these stories, and not to suddenly stop taking the... Read more